On June 18, 2025, GeneDx Holdings Corp. held its Annual Meeting where stockholders elected two directors and ratified the appointment of Ernst & Young as auditors, with strong votes of approval for both proposals. A total of 28,533,204 shares were outstanding, showing significant participation from stockholders.